Niva Bupa Health Insurance Company Limited (NSE:NIVABUPA)
India · Delayed Price · Currency is INR 85.00
-1.39 (-1.61%)
Aug 11, 2026, 3:29 PM IST
NSE:NIVABUPA Stock Forecast
Stock Price Forecast
According to 11 analysts polled by S&P Global, NSE:NIVABUPA stock has a consensus rating of "Buy" and an average price target of ₹99.80. The average 1-year stock price forecast is 17.41% higher than the current stock price, while the lowest is ₹90.00 (+5.88%) and the highest is ₹105.00 (+23.53%).
Price Target: ₹99.80 (+17.41%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for NSE:NIVABUPA stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 4 | 4 | 4 |
| Buy | 5 | 5 | 5 | 5 | 6 | 6 |
| Hold | 2 | 2 | 2 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 10 | 10 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Buy Maintains ₹100.00 → ₹105.00 | Buy | Maintains | ₹100.00 → ₹105.00 | +23.53% | Jul 31, 2026 |
| Motilal Oswal | Motilal Oswal | Buy Maintains ₹100.00 | Buy | Maintains | ₹100.00 | +17.65% | Jun 19, 2026 |
Financial Forecast
Revenue This Year
98.30B
from 84.43B
Increased by 16.42%
Revenue Next Year
121.62B
from 98.30B
Increased by 23.72%
EPS This Year
2.62
from 0.71
Increased by 268.87%
EPS Next Year
3.39
from 2.62
Increased by 29.44%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.